What Are the Downsides of Platelet-Rich Plasma (PRP)?

Platelet-rich plasma therapy carries a range of downsides that clinics often understate, from genuinely weak evidence for many of its popular uses to real risks of infection, tissue damage, and wasted money. Because PRP is made from your own blood, it gets marketed as inherently safe and natural, but “autologous” does not mean “risk-free,” and the science behind many PRP applications is far less settled than the promotional materials suggest.

The Evidence Is Weaker Than the Marketing Implies

The single biggest downside of PRP may be that for several of its most common uses, rigorous trials have failed to show it works meaningfully better than a placebo injection. In one of the largest and most carefully designed studies on knee osteoarthritis, patients who received PRP injections and those who received saline placebo injections reported nearly identical improvements in pain after twelve months, and there was no difference in cartilage volume loss between the two groups. Of 31 secondary outcomes measured, 29 showed no significant difference.

Achilles tendon problems tell a similar story. A systematic review with meta-analysis comparing PRP to placebo for chronic midsubstance Achilles tendinopathy found no difference in clinical outcomes at three, six, or twelve months.² That matters because Achilles tendon injuries are one of the conditions where PRP is most aggressively promoted, particularly among athletes and weekend warriors willing to pay out of pocket for anything that might speed recovery.

Hair loss treatment is another area where PRP has gained enormous commercial popularity. Yet a systematic review and meta-analysis of randomized trials examining PRP for androgenic alopecia concluded that the studies were highly heterogeneous, of low quality, and showed evident publication bias.³ In plain terms, the positive results you see cited in clinic brochures come disproportionately from small, poorly controlled trials, and the evidence base as a whole is unreliable. A separate meta-analysis of PRP for female hair loss found that effects on hair density and thickness varied with dosage, injection duration, and ethnicity, underscoring how unpredictable the therapy remains even when it does seem to help.⁴

Pain, Swelling, and Inflammatory Flare-Ups

PRP is often described as having “minimal side effects,” but the short-term reality can be unpleasant. Increased pain and swelling at the injection site are among the most commonly reported reactions. A meta-analysis covering 32 studies of intra-articular PRP injections that included white blood cells (a formulation known as leukocyte-rich PRP) specifically flagged increased pain and swelling as adverse effects.⁵ The inflammatory compounds released by white blood cells in those preparations can temporarily make the treated area feel worse before any potential benefit kicks in, and for some patients, the flare is severe enough to need additional treatment.

More unusual inflammatory reactions are possible, too. In one documented case, a 57-year-old man who was at risk for gout received PRP injections in his knee to treat osteoarthritis. Within 24 hours he developed acute pain and swelling and was diagnosed with a suspected gout attack. Researchers speculated that uric acid released from broken-down platelets triggered the inflammatory cascade associated with gout.⁶ That kind of reaction is rare, but it illustrates how PRP can provoke unexpected problems in people with underlying conditions.

Beyond gout, a literature survey of adverse events from PRP therapy identified postoperative infections as the most commonly reported problem, followed by blindness (in facial and eye-area applications), chronic inflammation, allergic reactions, and nodule development at the injection site.⁶ The fact that PRP comes from your own body does not eliminate the possibility of an allergic-type response, because the preparation process introduces materials like anticoagulants and activators that are not part of your blood.

Infection Is a Real, Not Hypothetical, Risk

Because PRP involves drawing blood, processing it, and reinjecting it, there are multiple points where bacteria can enter the preparation. A study examining microbial contamination risks in PRP therapy found contamination opportunities during both the initial blood draw and during the production steps that follow. The researchers concluded that improved disinfection protocols for venipuncture sites and better blood collection methods were needed to reduce these risks, and that microbial contamination could not be completely eliminated with current practices.⁷

This is worth emphasizing because PRP is often administered outside of hospital settings, in outpatient clinics and sports medicine offices where sterile processing infrastructure may be less robust. Unlike manufactured pharmaceuticals that undergo batch testing before reaching a patient, PRP is typically prepared chair-side and injected within minutes. There is no standard quality-control step to confirm the product is sterile before it goes into your joint, scalp, or tendon.

No Two PRP Preparations Are Alike

One of the most fundamental problems with PRP is that the term covers a wide spectrum of preparations that differ in ways that matter clinically. Variability in platelet count, white blood cell content, red blood cell contamination, and the method used to activate the platelets all complicate efforts to standardize PRP products or compare results across clinics.⁵ Two patients walking into two different clinics for “PRP” may receive products with very different biological properties, and even the same patient’s blood drawn on two different days can yield a different product depending on hydration, diet, and medication use.

Speaking of medications, common over-the-counter drugs can undermine the treatment. A systematic review found that aspirin, acetaminophen, and nonselective anti-inflammatory drugs should be stopped before a PRP injection because they can diminish the effects of the treatment by interfering with platelet function.⁸ COX-2 selective anti-inflammatories and statins did not appear to require suspension. The practical issue is that many patients take these medications daily and may not be adequately warned about the interaction, potentially paying hundreds of dollars for a treatment that is compromised from the start.

Potential for Deeper Tissue Harm

PRP is sometimes framed as purely regenerative, but animal research suggests it can promote unwanted changes in joint tissues. A study on knee osteoarthritis found that PRP aggravated synovial fibrosis compared to controls. The fibrosis was confirmed through multiple staining methods and through analysis of protein markers associated with scarring and tissue stiffening.⁹ Synovial fibrosis means the thin membrane lining the joint becomes thickened and scarred, which can contribute to stiffness and pain over time.

This finding is preliminary and comes from an animal model, so it would be wrong to say PRP definitely causes fibrosis in human joints. But it raises a concern that the growth factors in PRP, which are supposed to encourage healing, might instead stimulate the wrong kind of tissue growth in certain contexts. The long-term consequences of repeated PRP injections into the same joint over years remain poorly studied, and the assumption that repeated exposure is harmless deserves more scrutiny than it currently gets.

A Regulatory Gray Zone

PRP occupies an unusual regulatory position that most patients are not aware of. In the United States, numerous PRP preparation systems have received FDA 510(k) clearance, but that clearance is specifically for producing platelet-rich preparations intended to be mixed with bone graft materials in orthopedic surgery. Using PRP as a standalone injection for knee pain, hair loss, or tendon injuries is considered off-label.¹⁰

Off-label use is legal and common across medicine, so that fact alone is not damning. The problem is that many patients hear “FDA-cleared” and assume the treatment has been vetted for the condition they are being treated for, when it has not. PRP can be legally offered off-label for a wide range of musculoskeletal conditions, but clearance is not the same as approval, and the clinical trials that exist have not demonstrated definitive efficacy for most of those uses.¹¹ The researchers behind that assessment explicitly recommended that clinicians inform patients when providing PRP off-label, a step that not every clinic takes.

High Cost, No Insurance, Wide Price Variation

PRP is expensive, and in nearly all cases you will pay the full cost yourself. Because PRP is not FDA-approved for most indications, insurance companies almost never cover it. A survey of orthobiologic pricing found that the average cost of a single PRP injection was about $700, with prices ranging from $175 to nearly $5,000 depending on the provider.¹² A nationwide study of top orthopedic hospitals confirmed that pricing varies enormously from institution to institution, creating a landscape where patients have little ability to comparison shop or predict costs.¹³

The financial burden falls hardest on people who can least afford it. Without universal insurance coverage, PRP treatments remain inaccessible for many uninsured and lower-income patients, creating a disparity in who can even access these therapies.¹⁴ And because the evidence base is weak for many applications, the money spent on PRP may deliver no measurable benefit beyond what a cheaper alternative, or even a placebo injection, would provide.

Effects Fade, and Repeat Sessions Add Up

Even when PRP does produce symptomatic improvement, the benefits are temporary. Research on PRP for osteoarthritis has found that therapeutic effects peak within weeks of injection but tend to diminish over time without repeated doses. One research group developed a protocol involving monthly PRP injections over six months to try to sustain the benefits.¹⁵ That kind of schedule translates to thousands of dollars per treatment course, all out of pocket, with no guarantee that the improvement will last once injections stop.

Hair loss clinics often recommend similar repeated treatment cycles, sometimes three to four sessions spaced weeks apart followed by maintenance injections every few months indefinitely. The cumulative cost can rival surgical alternatives that produce more durable results, and stopping PRP for hair loss typically means any gains begin to reverse as the underlying condition continues.

Misleading Marketing and Informed Consent Gaps

The commercial ecosystem around PRP raises its own set of concerns. A scoping review of ethical issues in direct-to-consumer healthcare found that in-clinic commercial therapies, including those in the regenerative medicine space, were criticized for making unsubstantiated claims about how well treatments work, misleadingly marketing interventions as safe, and inaccurately claiming regulatory compliance.¹⁶ PRP clinics are not universally guilty of this, but the field operates in a space where marketing frequently outpaces evidence, and the patients paying for treatment often lack the scientific background to evaluate the claims being made.

You might encounter clinics citing impressive-sounding success rates that come from small, uncontrolled case series rather than randomized trials. You might be told that PRP is “FDA-cleared” without being told that the clearance is for a different use than what you are receiving. You might be shown before-and-after photos without being informed about the high variability in outcomes. None of this is unique to PRP; it is common across cash-pay medical procedures. But the combination of genuine biological plausibility (platelets really do release growth factors), weak regulatory oversight, and high patient desperation makes PRP an area where the gap between marketing and evidence is particularly wide.

Who Should Think Twice

Certain groups face elevated risk or are especially likely to waste money on PRP. If you have a bleeding disorder, an active infection near the treatment site, or are on blood thinners that cannot be safely paused, PRP is generally not recommended. People with autoimmune conditions may respond unpredictably to the inflammatory signals released by activated platelets. And as the gout case illustrates, anyone with crystal-deposition diseases should discuss the risk of a flare with their physician before proceeding.

People taking daily aspirin or over-the-counter pain relievers should be aware that these medications can compromise the treatment, and should confirm with their provider whether and when to stop them. If a clinic does not ask about your medication history before performing PRP, that is a red flag about the level of care you are receiving.

Perhaps the broadest category of people who should think twice is anyone being offered PRP for a condition where strong evidence of benefit does not yet exist. For knee osteoarthritis, for Achilles tendinopathy, and for hair loss, the best available evidence suggests that PRP performs no better or only marginally better than placebo. That does not mean it cannot help individual patients, but it does mean the odds of spending several hundred to several thousand dollars on something that does not work are uncomfortably high. If your provider cannot point you to high-quality randomized trial data supporting PRP for your specific condition, that absence of evidence is itself a meaningful downside worth weighing before you commit.

1
PubMed Central. Effect of Intra-articular Platelet-Rich Plasma vs Placebo Injection on Pain and Medial Tibial Cartilage Volume in Patients With Knee Osteoarthritis: The RESTORE Randomized Clinical Trial
2
Foot and Ankle Surgery. Evidence for the use of PRP in chronic midsubstance Achilles tendinopathy: A systematic review with meta-analysis
3
Anais Brasileiros de Dermatologia. Is autologous platelet-rich plasma capable of increasing hair density in patients with androgenic alopecia? A systematic review and meta-analysis of randomized clinical trials
4
PubMed Central. Effectiveness of platelet-rich plasma in treating female hair loss: A systematic review and meta-analysis of randomized controlled trials
5
Acta Biomaterialia. Platelet-rich plasma – A comprehensive review of isolation, activation, and application
6
PubMed Central. Adverse events related to platelet-rich plasma therapy and future issues to be resolved
7
Regenerative Therapy. Microbial contamination risks and clinical safety in platelet-rich plasma therapy and evaluation of rapid microbial detection methods
8
PubMed Central. A Systematic Review on the Effect of Common Medications on Platelet Count and Function: Which Medications Should Be Stopped Before Getting a Platelet-Rich Plasma Injection?
9
PubMed. The Effect of Platelet-Rich Plasma on Synovial Fibrosis and Cartilage Degeneration in Knee Osteoarthritis
10
PubMed. US definitions, current use, and FDA stance on use of platelet-rich plasma in sports medicine
11
PubMed Central. The Economics and Regulation of PRP in the Evolving Field of Orthopedic Biologics
12
Orthopaedic Journal of Sports Medicine. The Cost Variability of Orthobiologics
13
PubMed Central. There Is Wide Variation in Platelet-rich Plasma Injection Pricing: A United States Nationwide Study of Top Orthopaedic Hospitals
14
PubMed Central. The Cost of PRP: Disparities in orthobiologic utilization
15
PubMed Central. Optimal frequency of platelet-rich plasma injections for managing osteoarthritis: A longitudinal study
16
PubMed Central. Ethical issues in direct-to-consumer healthcare: A scoping review